Related Experiment Video
Updated: Apr 11, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.8K
Management of exfoliative glaucoma: challenges and solutions
Gábor Holló1, Andreas Katsanos2, Anastasios Gp Konstas3
1Department of Ophthalmology, Semmelweis University, Budapest, Hungary.
Clinical Ophthalmology (Auckland, N.Z.)
|June 6, 2015
Summary
Exfoliative glaucoma, a common secondary open-angle glaucoma, requires managing high intraocular pressure (IOP) with treatments like medication, laser, and surgery. Effective long-term care focuses on sustained low IOP and 24-hour control to prevent disease progression.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Secondary Glaucoma
Background:
- Exfoliative glaucoma is the leading cause of secondary open-angle glaucoma globally.
- It presents with elevated intraocular pressure (IOP) and poor 24-hour IOP control.
- Effective management is crucial to prevent disease progression.
Purpose of the Study:
- To review current medical, laser, and surgical treatment options for exfoliative glaucoma.
- To emphasize the importance of long-term IOP management.
- To provide guidance for general ophthalmologists managing this condition.
Main Methods:
- Review of current literature on exfoliative glaucoma management.
- Analysis of medical, laser, and surgical treatment outcomes.
- Discussion of interdisciplinary approaches for elderly patients with comorbidities.
Main Results:
- Various treatment modalities including fixed-dose eye drops, laser trabeculoplasty, and surgical interventions are effective.
- Achieving sustained low mean IOP and consistent 24-hour IOP control is key.
- Interdisciplinary consultation is vital due to the disease's prevalence in the elderly and association with vascular conditions.
Conclusions:
- Comprehensive management strategies are necessary for exfoliative glaucoma.
- A combination of medical, laser, and surgical options should be tailored to individual patient needs.
- Long-term monitoring and management are essential for optimal patient outcomes.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:23Ophthalmic Drug Delivery Systems
245
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
245